Dynamic correlation networks in human peroxisome proliferator-activated receptor-γ nuclear receptor protein

被引:0
|
作者
Jeremy Fidelak
Silvia Ferrer
Michael Oberlin
Dino Moras
Annick Dejaegere
Roland H. Stote
机构
[1] Institut de Génétique et de Biologie Moléculaire et Cellulaire,Structural Biology and Genomics Department
来源
关键词
Molecular dynamics; Nuclear receptor; Allostery; Normal mode; Protein;
D O I
暂无
中图分类号
学科分类号
摘要
Peroxisome proliferator-activated receptor-γ nuclear receptor (PPAR-γ) belongs to the superfamily of nuclear receptor proteins that function as ligand-dependent transcription factors and plays a specific physiological role as a regulator of lipid metabolism. A number of experimental studies have suggested that allostery plays an important role in the functioning of PPAR-γ. Here we use normal-mode analysis of PPAR-γ to characterize a network of dynamically coupled amino acids that link physiologically relevant binding surfaces such as the ligand-dependent activation domain AF-2 with the ligand binding site and the heterodimer interface. Multiple calculations were done in both the presence and absence of the agonist rosiglitazone, and the differences in dynamics were characterized. The global dynamics of the ligand binding domain were affected by the ligand, and in particular, changes to the network of dynamically correlated amino acids were observed with only small changes in conformation. These results suggest that changes in dynamic couplings can be functionally significant with respect to the transmission of allosteric signals.
引用
收藏
页码:1503 / 1512
页数:9
相关论文
共 50 条
  • [1] Dynamic correlation networks in human peroxisome proliferator-activated receptor-γ nuclear receptor protein
    Fidelak, Jeremy
    Ferrer, Silvia
    Oberlin, Michael
    Moras, Dino
    Dejaegere, Annick
    Stote, Roland H.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2010, 39 (11): : 1503 - 1512
  • [2] Inflammation in diabetes mellitus:: Role of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ agonists
    Libby, Peter
    Plutzky, Jorge
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (4A): : 27B - 40B
  • [3] Peroxisome proliferator-activated receptor-γ and lipodystrophy
    Tantsma, Jouke T.
    Rabelink, Ton J.
    FUTURE LIPIDOLOGY, 2006, 1 (04): : 455 - 462
  • [4] Peroxisome proliferator-activated receptor-α -: Friend or foe?
    Yagil, Chana
    Yagil, Yoram
    HYPERTENSION, 2007, 50 (05) : 847 - 850
  • [5] Curcumin is not a ligand for peroxisome proliferator-activated receptor-γ
    Narala, Venkata R.
    Smith, Monica R.
    Adapala, Ravi K.
    Ranga, Rajesh
    Panati, Kalpana
    Moore, Bethany B.
    Leff, Todd
    Reddy, Vudem D.
    Kondapi, Anand K.
    Reddy, Raju C.
    GENE THERAPY AND MOLECULAR BIOLOGY, 2009, 13 (01): : 20 - 25
  • [6] Peroxisome proliferator-activated receptor-γ and esophageal cancer
    Shimada, T
    Terano, A
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2002, 140 (01): : 4 - 5
  • [7] Peroxisome proliferator-activated receptor-γ in the renal mesangium
    Hsueh, WA
    Nicholas, SB
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2002, 11 (02): : 191 - 195
  • [8] Peroxisome proliferator-activated receptor-? cofactors in neurodegeneration
    Katsouri, Loukia
    Blondrath, Katrin
    Sastre, Magdalena
    IUBMB LIFE, 2012, 64 (12) : 958 - 964
  • [9] Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
    Ferrari, Silvia Martina
    Fallahi, Poupak
    Vita, Roberto
    Antonelli, Alessandro
    Benvenga, Salvatore
    PPAR RESEARCH, 2015, 2015
  • [10] Peroxisome proliferator-activated receptor-γ expression in lung
    Inoue, K
    Kawahito, Y
    Sano, H
    CHEST, 2002, 122 (01) : 386 - 387